Repligen Corp - נכסים נקיים למניה בודדת RGEN

Repligen Corporation (RGEN) production sites are operating at full capacity, expanding sterile workshops to reduce the order backlog. This price chart reflects a market trend characterized by low business sensitivity to economic cycles and macroeconomic shocks. The current indicator is 37.61. Repligen Corporation (RGEN) revenues are based on the supply of chromatography systems and filters to global laboratories and gene therapy developers.

Book value per share determines the net asset value of an enterprise attributable to a single security. This metric allows for an assessment of the company's intrinsic value and determines the capital safety margin. By analyzing the calculated book value per share, an investor identifies risks of undervaluation or excessive leverage. For Repligen Corporation (RGEN), this indicator reflects the tangible basis for the production of high-tech biopharmaceutical equipment. The capitalization of physical assets confirms the company's status as a reliable technological industry leader.